NO983090L - Terapeutiske forbindelser - Google Patents

Terapeutiske forbindelser

Info

Publication number
NO983090L
NO983090L NO983090A NO983090A NO983090L NO 983090 L NO983090 L NO 983090L NO 983090 A NO983090 A NO 983090A NO 983090 A NO983090 A NO 983090A NO 983090 L NO983090 L NO 983090L
Authority
NO
Norway
Prior art keywords
therapeutic compounds
relates
benzimidazole derivatives
prophylaxis
preparation
Prior art date
Application number
NO983090A
Other languages
English (en)
Norwegian (no)
Other versions
NO983090D0 (no
Inventor
Stanley Dawes Chamberlain
George Walter Koszalka
Jeffrey H Tidwell
Nanine Agneta Van Draanen
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO983090D0 publication Critical patent/NO983090D0/no
Publication of NO983090L publication Critical patent/NO983090L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO983090A 1996-01-05 1998-07-03 Terapeutiske forbindelser NO983090L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600143.3A GB9600143D0 (en) 1996-01-05 1996-01-05 Therapeutic compounds
PCT/GB1996/003151 WO1997025337A1 (en) 1996-01-05 1996-12-19 Therapeutic compounds

Publications (2)

Publication Number Publication Date
NO983090D0 NO983090D0 (no) 1998-07-03
NO983090L true NO983090L (no) 1998-09-01

Family

ID=10786611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983090A NO983090L (no) 1996-01-05 1998-07-03 Terapeutiske forbindelser

Country Status (21)

Country Link
US (2) US6204249B1 (xx)
EP (1) EP0876389A1 (xx)
JP (1) JP2000515119A (xx)
KR (1) KR19990077041A (xx)
CN (1) CN1214049A (xx)
AP (1) AP9801286A0 (xx)
AU (1) AU729541B2 (xx)
BR (1) BR9612413A (xx)
CA (1) CA2241993A1 (xx)
CZ (1) CZ212698A3 (xx)
EA (1) EA001770B1 (xx)
GB (1) GB9600143D0 (xx)
HU (1) HUP9904301A3 (xx)
IS (1) IS4789A (xx)
MX (1) MX9805441A (xx)
NO (1) NO983090L (xx)
NZ (1) NZ324380A (xx)
OA (1) OA10707A (xx)
PL (1) PL327732A1 (xx)
TR (1) TR199801289T2 (xx)
WO (1) WO1997025337A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007125A1 (en) * 1995-08-18 1997-02-27 The Regents Of The University Of Michigan 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
GB9600143D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
JP2001512453A (ja) 1997-02-13 2001-08-21 グラックス グループ リミテッド ベンゾイミダゾール誘導体
AU741772B2 (en) 1997-02-25 2001-12-06 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
PL338454A1 (en) 1997-07-30 2000-11-06 Univ Michigan Lixofuranosilbenzimidazoles as antiviral agents
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807355D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
CA2550441C (en) * 2003-12-26 2012-08-28 Kissei Pharmaceutical Co., Ltd. Benzimidazole derivatives and medical uses thereof
EP2210896A1 (en) * 2007-10-05 2010-07-28 API Corporation Process for production of ribofuranose derivatives
US12043644B2 (en) * 2020-06-23 2024-07-23 Biometrix Technology Inc Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent or anti-virus agent comprising the same
AU2023361470A1 (en) 2022-10-12 2024-09-19 Takeda Pharmaceutical Company Limited Method of preparing maribavir
WO2024103979A1 (zh) * 2022-11-17 2024-05-23 北京凯因科技股份有限公司 一种抑制疱疹病毒的化合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE130030C (xx)
US3399987A (en) 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
US3655901A (en) 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
US4002623A (en) 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
FR2551442B1 (fr) 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
EP0304624A3 (de) 1987-07-29 1989-03-22 F. Hoffmann-La Roche Ag Benzimidazol-2-yl-pyridiniumverbindungen
IT1226100B (it) 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
SE9003151D0 (sv) 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
WO1992018517A1 (en) 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
ZA923641B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
WO1994008456A1 (en) * 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
GB9226879D0 (en) 1992-12-23 1993-02-17 Iaf Biochem Int Anti-viral compounds
US5399580A (en) 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
WO1997007125A1 (en) 1995-08-18 1997-02-27 The Regents Of The University Of Michigan 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
GB9600143D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
US5995610A (en) * 1997-05-06 1999-11-30 Telefonaktiebolaget Lm Ericsson Cooperative call processing across public and private intelligent networks

Also Published As

Publication number Publication date
EA199800526A1 (ru) 1999-04-29
WO1997025337A1 (en) 1997-07-17
IS4789A (is) 1998-06-30
BR9612413A (pt) 1999-07-13
PL327732A1 (en) 1998-12-21
CZ212698A3 (cs) 1998-12-16
GB9600143D0 (en) 1996-03-06
OA10707A (en) 2001-05-09
CA2241993A1 (en) 1997-07-17
JP2000515119A (ja) 2000-11-14
HUP9904301A2 (hu) 2000-05-28
HUP9904301A3 (en) 2001-07-30
AU1164097A (en) 1997-08-01
AP9801286A0 (en) 1998-09-30
EA001770B1 (ru) 2001-08-27
US6617315B1 (en) 2003-09-09
EP0876389A1 (en) 1998-11-11
MX9805441A (es) 1998-11-30
CN1214049A (zh) 1999-04-14
KR19990077041A (ko) 1999-10-25
NO983090D0 (no) 1998-07-03
NZ324380A (en) 2000-01-28
US6204249B1 (en) 2001-03-20
AU729541B2 (en) 2001-02-01
TR199801289T2 (en) 1998-10-21

Similar Documents

Publication Publication Date Title
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
TR199903053T2 (xx) Benzimidazol t�revleri.
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
BR9907270A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto
ATE245641T1 (de) Antivirale pyrimidinderivate
NO875209L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5-substituerte pyrimidinnukleosider.
NO983090L (no) Terapeutiske forbindelser
MY130035A (en) Antiviral compounds
DK224286D0 (da) 2',3'-dideoxy-nucleosider
BR0316407A (pt) Derivados de nucleosìdeo antiviral
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9909474A (pt) Formas ii, cristalina e v de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol, solvato de etanol de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol, composição, composto, uso de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol, e, processos para o tratamento de uma infecção viral em um humano e para a produção de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol
DK1124841T3 (da) Substituerede phenylalkenoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler eller diagnosemidler og lægemidler, som indeholder dem
BG103959A (en) Carbocyclic nucleoside hemisulphate and its application in the treatment of viral infections
DK0777669T3 (da) 4-[2-amino-6-(cyclopropylamino)-9H-purin-yl]-2-cyclopenten-1-methanolsuccinat som antiviralt middel
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
BR9909471A (pt) Formas vi e cristalina de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol, composição, composto, uso de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol, e, processos para o tratamento ou profilaxia de uma infecção viral em ser humano e para a produção de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol
NO991589L (no) Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler
MX9303985A (es) Nucleosidos terapeuticos.
DK0479822T3 (da) Terapeutiske nucleosider
MX9302578A (es) Agentes antivirales.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application